Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases

PHASE2UnknownINTERVENTIONAL

Enrollment

130

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2012

Conditions

Breast Cancer

Interventions

DRUG

RAD001

Tablet of 5 mg, 2 tablets (10 mg) are taken once daily during study therapy

DRUG

Placebo

2 tablets are taken once daily during study therapy

Trial Locations (1)

Dr. med. Christoph Mundhenke, Kiel